Skip to content

To evaluate the effect of Laghushankhaprakshalana (LSP) in the management of vataj grahani roga W.S.R Irritable bowel syndrome [IBS]

To evaluate the effect of Laghushankhaprakshalana (LSP) in the management of vataj grahani roga W.S.R Irritable bowel syndrome [IBS]- A comparative randomized controlled open label clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077227
Enrollment
69
Registered
2024-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

All India Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ICD-11 Irritable bowel syndrome, constipation predominant (DD91.00) Irritable bowel syndrome, diarrhoea predominant (DD91.01) Irritable bowel syndrome, mixed type (DD91.02) Irritable bowel syndrome, unsubtyped (DD91.03) Irritable bowel syndrome, type unspecified (DD91.0Z) Age: 18-50 years Gender-both males & females. Patients having pratyatma lakshana of Grahani Roga especially –Atisrushtam malapravritti, Ativibadhham malapravritti, Atidravam malapravritti, Udara Shula (pain in abdomen), Anaha (distention of abdomen), Mala Tyaga Asantushti (dissatisfaction after defecation), Kapha Nihssarana (mucus in stool), Udara Atopa (tympanitis), Bhojanopranta Mala Tyaga (defecation after taking meals), Shuktpaka, Mana sadnam, Kruchapaka, Alteration of bowel habit (Shushka, Tanu, Apkwa, Phenyukta Malapravrutti)& The patients who are diagnosed with IBS according to standard ROME IV criteria. Patient with symptom onset at least 6 months prior to diagnosis. Willing to give written informed consent.

Exclusion criteria

Exclusion criteria: Previously diagnosed cases and history of Ulcerative colitis, Crohn’s disease, gastric ulcerations, Intestinal tuberculosis and other inflammatory bowel conditions. Mixed infection with parasites such as round worms, hook worms, & lactose intolerance patients. Patients with evidence of malignancy. Patients with Diabetes Mellitus. Patient with poorly controlled Hypertension Abuse of drug or alcohol. Presence of other somatic or mental disorder requiring medication. Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study. Pregnant & lactating women. Systemic disorders like respiratory, cardiac, renal, nervous, Degenerative disorders BMI above 40

Design outcomes

Primary

MeasureTime frame
75% reduction in signs and symptoms of vataj ggrahani roga as well IBS Severity Score Scale(IBS SSS).Timepoint: At Baseline, 14th day-28th day-42nd day-56th day-70th day-84th day and at the end of follow up after 18th week

Secondary

MeasureTime frame
Overall improvement in the quality of lifeTimepoint: At Baseline, 14th day-28th day-42nd day-56th day-70th day-84th day and at the end of follow up after 18th week

Countries

India

Contacts

Public ContactProf Dr Medha Kulkarni

All India Institute Of Ayurveda Gautampuri Sarita Vihar New Delhi South DELHI 110076 India

Medha63@rediffmail.com9890355305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026